Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the viral inactivation market grown over the years?
The market size of viral inactivation has experienced substantial growth in the past few years. From 2024 to 2025, it is projected to increase from $5.01 billion to $5.48 billion, growing at a compound annual growth rate (CAGR) of 9.4%. The surge during the historic period can be traced back to the global increase in air traffic, advanced navigation abilities, expansion of commercial aviation, cost-effective airline operations, improved flight safety measures, and decrease in pilot workload.
What Is the forecasted market size and growth rate for the viral inactivation market?
The expansion of the viral inactivation market is projected to surge swiftly in the forthcoming years, reaching a value of “$8.28 billion in 2029, with a compound growth rate (CAGR) of 10.9%. This expected increase during the forecast period is credited to the development of independent flight technologies, innovative designs for future aircraft, sustainable aviation strategies, urban air mobility (UAM), and a rising demand for aircraft. Key trends during this forecast period include the incorporation of cutting-edge avionics, the deployment of artificial intelligence, advances in human-machine interface (HMI), modernization of existing aircraft, and the integration of the global navigation satellite system (GNSS).
Get your viral inactivation market report here!
https://www.thebusinessresearchcompany.com/report/viral-inactivation-global-market-report
What are the major factors driving growth in the viral inactivation market?
The rise in different infectious diseases is anticipated to drive the expansion of the viral inactivation market. These diseases, which can spread from one person to another through contaminated food and drinks, and due to pathogens like viruses, bacteria, fungi, and parasites, necessitates the use of viral inactivation. This method, which effectively uses physical and chemical disinfectants to neutralize viruses, is crucial in human disease prevention programs, thereby contributing to the growth of the viral inactivation market. For example, the Centers for Disease Control and Prevention, a US-based national public health agency, reported in March 2024 that tuberculosis cases rose from 8,320 in 2022 to 9,615 in 2023, marking an increase of 1,295 cases. The rate also went up from 2.5 per 100,000 persons in 2022 to 2.9 in 2023. Consequently, the rising occurrences of several infectious diseases are fueling the expansion of the viral inactivation market.
What key areas define the segmentation of the global viral inactivation Market?
The viral inactivation market covered in this report is segmented –
1) By Product: Kits And Reagents, Systems, Services
2) By Method: Solvent Detergent Method, pH Adjustment Method, Pasteurization, Other Methods
3) By Application: Vaccines And Therapeutics, Tissues And Tissue Products, Blood And Blood Products, Other Applications
4) By End User: Pharmaceutical And Biotechnology Companies, Contract Research Organizations, Blood Banks, Hospital, Academic Research Institutes, Other End Users
Subsegments:
1) By Kits And Reagents: Viral Inactivation Kits, PCR Reagents, Antibodies and Enzymes
2) By Systems: Automated Viral Inactivation Systems, Batch Viral Inactivation Systems, Continuous Flow Systems
3) By Services: Viral Testing Services, Validation Services, Consulting Services
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10401&type=smp
What are the top market players propelling the growth of the viral inactivation industry?
Major companies operating in the viral inactivation market include Merck & Co. Inc., Sartorius AG, Texcell SA, SGS SA, Charles River Laboratories Inc., Clean Cells SAS, Rad Source Technologies, WuXi AppTec, Sigma-Aldrich Co. LLC, Thermo Fisher Scientific Inc., Macopharma, Cerus Corporation, TERUMO BCT INC., Shandong Weigao Group Medical Polymer Co. Ltd., Pall Corporation And Eurofins Scientific, General Electric Company, Cytiva, Mettler Toledo, Viral Inactivated Plasma Systems SA, Eurofins Scientific SE, Lonza Group AG, Avantor Inc., Bio-Rad Laboratories Inc., F. Hoffmann-La Roche AG, Fujifilm Holdings Corporation, Pfizer Inc., Novartis AG, Gilead Sciences Inc., Johnson & Johnson Private Limited
What are the key trends shaping the future of the viral inactivation market?
A prevalent trend emerging in the viral inactivation market is the increasing implementation of cutting-edge technologies. Firms working in this sector are embracing top-tier tech processes to maintain market relevance. For example, WuXi Advanced Therapies, fully owned by WuXi AppTec (a China-based bioscience company), unveiled its Tetracycline-Enabled Self-Silencing Adenovirus (TESSA) Technology in March 2022. This revolutionary technology has simplified the approval of novel therapies by concomitantly executing assay formulation, biosafety, viral purification, product launch, and checks, all from within their premises. This procedure presents a groundbreaking technique for generating Good Manufacturing Practices (GMP) grade adeno-associated virus (AAV) without the requirement for transfection.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10401
What regions are dominating the viral inactivation market growth?
North America was the largest region in the viral inactivation market in 2024. Asia-pacific is expected to be the fastest-growing region in the global viral inactivation market during the forecast period. The regions covered in the viral inactivation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Healthcare E-Commerce Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/healthcare-ecommerce-global-market-report
Healthcare Personal Protective Equipment Global Market Report 2024
Pharmacies and Healthcare Stores Global Market Report 2024
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
